Effect of green tea on the cardiovascular system
DOI:
https://doi.org/10.12775/JEHS.2023.46.01.014Keywords
Flavonoids, Cardiovascular Diseases, green teaAbstract
Cardiovascular diseases (CVD) are among the leading causes of mortality worldwide, causing significant public health concerns. Flavonoids, abundant in green tea, have been found to play a pivotal role in their prevention and treatment. These compounds exert beneficial effects on vascular endothelium through various mechanisms, including enhancing nitric oxide production, reducing LDL cholesterol levels, and inhibiting platelet aggregation. Dietary principles tailored to individual risk factors are also vital for individuals with CVD. Studies suggest that green tea may be a promising tool for preventing CVD due to its antioxidative, anti-inflammatory, anti-carcinogenic, and antiplatelet effects. Catechins in green tea have been demonstrated to modify various risk factors, thereby reducing overall CVD risk. Epidemiological studies have reported an inverse association between green tea consumption and mortality from CVD. The beneficial properties of green tea, especially among non-smokers and rural residents, underscore its potential role in managing CVD risk. Further research on the effect of green tea on vascular health is warranted.
References
Caprari M. Czas na herbatę. [Time for Tea]. Warszawa: Klub Dla Ciebie; 2008. p.16-19. Polish.
Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein AM, Taylor PR. Jasmine tea consumption and upper gastrointestinal cancer in china. Cancer Causes Control. 2009;20:1997-2007.
Fik M, Zawiślak A. Porównanie właściwości przeciwutleniających wybranych herbat. [Comparison of antioxidant properties of selected teas]. Żywność. Nauka. Technologia. Jakość. 2004;3(40):98-105. Polish.
Cichoń Z. Właściwości zielonej herbaty. [Properties of green tea]. Zeszyty Naukowe UEK. 2007;743:59-90. Polish.
Fiedoruk A. Herbata bez tajemnic. [Tea without secrets]. Białystok: Instytut Wydawniczy Kreator; 2004. p.11-12, 20-36. Polish.
Kwok CS, Jackson R, Cheung CS, Yau MY, Preece R, Armstrong E, Rushton C, Loke YK. Habitual Tea Consumption and Risk of Frailty in Older Adults: A Prospective Cohort Study. Nutrients. 2019;12(1):134.
Di Castelnuovo A, Di Giuseppe R, Iacoviello L, Gaetano G. Consumption of cacao, tea and coffee and risk of cardiovascular disease. Eur J Intern Med 2012;23:15-25.
Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997;37:693-704.
Stangl V, Lorenz M, Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res. 2006;50:218-28.
Ozkor MA, Murrow JR, Rahman AM, et al. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease. Circulation. 2011;123:2244-2253.
Dreosti IE. Antioxidant polyphenols in tea, cocoa, and wine. Nutrition. 2000;16:692-694.
Sasazuki S, Kodama H, Yoshimasu K, et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol. 2000;10:401-408.
Iwai N, Ohshiro H, Kurozawa Y, Hosoda T, Morita H, Funakawa K, Okamoto M, Nose T. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002;12:191-8.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(21):e28-e292.
Kokubo Y, Iso H, Saito I, et al. The impact of green tea and coffee consumption on the reduced risk of stroke risk in Japanese population: the Japan public health center-based study cohort. Stroke. 2013;44:1369-1374.
Suzuki E, Yorifuji T, Takao S, et al. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol. 2009;19:732-739.
Yang CS, Zhang J, Zhang L, Huang J, Wang Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res. 2016;60(1):160–174.
Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88(1):38-50.
Matyjaszczyk P, Hoffmann K, Bryl W. Epidemiologia wybranych czynników ryzyka chorób układu krążenia. Przeg Kardio. 2011;6:255-62.
Jochmann N, Baumann G, Stangl V. Green tea and cardiovascular disease: from molecular targets towards human health. Curr Opin Clin Nutr Metab Care. 2008;11(6):758-65.
Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65:230-240.
Kelley GA, Kelley KS, Tran ZV. Exercise, lipids, and lipoproteins in older adults: a meta-analysis. Prev Cardiol. 2005;8:206-214.
Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;13:1255-1265.
Geleijnse JM, Launer LJ, Van der Kuip DA, et al. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002;75:880-6.
Wang ZM, Zhou B, Wang YS, et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 2011;93:506-15.
Liu J, Liu S, Zhou H, et al. Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men. Eur J Epidemiol. 2016.
Shin S, Lee JE, Loftfield E, et al. Coffee and tea consumption and mortality from all causes, cardiovascular disease and cancer: a pooled analysis of prospective studies from the Asia Cohort Consortium. Int J Epidemiol. 2022;51(2):626-640.
Hodgson JM, Croft KD. Tea flavonoids and cardiovascular health. Mol Aspects Med. 2010;31:495-502.
Moore RJ, Jackson KG, Minihane AM. Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr. 2009;102:1790-802.
Wang QM, Gong QY, Yan JJ, Zhu J, Tang JJ, Wang MW, et al. Association between green tea intake and coronary artery disease in a Chinese population. Circ J 2010;74:294-300.
Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem. 2007;18:179-83.
Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95(3):740-51.
Tudor-Locke C, Bassett DR Jr, Rutherford WJ, et al. BMI- referenced cut points for pedometer-determined steps per day in adults. J Phys Act Health. 2008;5 (Suppl 1): S126- S139.
Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 2007;15(6):1473-83.
Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 2008;138(8):1548S-1553S.
Tinahones FJ, Rubio MA, Garrido-Sanchez L, et al. Green tea reduces LDL oxidability and improves vascular function. J Am Coll Nutr. 2008;27:209-13.
Cai Y, Kurita-Ochiai T, Hashizume T, et al. Green tea epigallocatechin-3- gallate attenuates Porphyromonas gingivalis-induced atherosclerosis. Pathog Dis. 2013;67:76-83.
Lee SM, Kim CW, Kim JK, et al. GCG-rich tea catechins are effective in lowering cholesterol and triglyceride concentrations in hyperlipidemic rats. Lipids. 2008;43:419-429.
Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD. Pure dietary flavonoids, quercetin and (-)- epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy human volunteers. Am J Clin Nutr. 2008;88:1018-25.
Hodgson JM, Croft KD. Dietary flavonoids: effects on endothelial function and blood pressure. J Sci Food Agric. 2006;86:2492-8.
Sone T, Kuriyama S, Nakaya N, et al. Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr. Res. 2011;55:1-10.
Yang CS, Wang X. Green tea and cancer prevention. J Natl Cancer Inst. 2011;103(16):1221-2.
Cheng TO. All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol. 2006;14:301-308.
Ohishi T, Goto S, Monira P, Isemura M, Nakamura Y. Anti-inflammatory Action of Green Tea. Antiinflamm Antiallergy Agents Med Chem. 2016;15(2):74-90.
Khan N, Mukhtar H. Tea Polyphenols in Promotion of Human Health. Nutrients. 2018;11(1):39.
Smith AE, Lockwood CM, Moon JR et al. Physiological effects of caffeine, epigallocatechin-3-gallate, and exercise in overweight and obese women. Appl Physiol Nutr Metab. 2010; 35: 607-616.
Landini L, Rebelos E, Honka MJ. Green Tea from the Far East to the Drug Store: Focus on the Beneficial Cardiovascular Effects. Curr Pharm Des. 2021;27(16):1931-1940.
Zamani M, Kelishadi MR, Ashtary-Larky D, Amirani N, Goudarzi K, Torki IA, Bagheri R, Ghanavati M, Asbaghi O. The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis. Front Nutr. 2023;9:1084455.
Werba JP, Misaka S, Giroli MG, Shimomura K, Amato M, Simonelli N, Vigo L, Tremoli E. Update of green tea interactions with cardiovascular drugs and putative mechanisms. J Food Drug Anal. 2018;26(2S):S72-S77.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jakub Maternia, Karolina Miszczyk, Patrycja Maj, Natalia Sergiel, Agata Kania, Malwina Gonet, Karolina Włodarczyk-Cybulska, Piotr Mozer, Michał Lazar, Aleksandra Serwik-Trandasir
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 520
Number of citations: 0
